Overview This is a safety and dose finding study looking at Oxaloacetate (OAA) in patients with Amyotrophic Lateral Sclerosis (ALS). This study will aim to determine the maximal dose that a person can tolerate. We will also learn how OAA affects mitochondria in subjects with ALS. This is a 28 day